Peptide Endotoxin and Sterility Testing: The COA Section Almost Nobody Publishes

A certificate of analysis showing 99.5% HPLC purity and a matching mass-spec identity tells you what the molecule is and how much of the material is that molecule. It tells you nothing about whether the vial contains viable bacteria or bacterial endotoxin, because neither instrument can see them. Contamination is measured by two entirely separate tests: a culture-based sterility test (USP General Chapter <71>) and a bacterial endotoxin test reported in Endotoxin Units, run by LAL under USP <85> or by recombinant reagents under USP <86>. Almost every peptide COA in this market stops at purity and identity. So the checkable question is not “does this vendor publish a COA” but “does the published report contain a contamination section at all, and if not, does the vendor say so plainly instead of letting a purity number imply it.”

Published 2026 - For research use only (RUO). Nothing here is medical advice, a dosing protocol, or a human-use recommendation. This page describes laboratory quality-control methods for research material, not safety criteria for administration to humans or animals.

In a hurry? Jump to how Pepora scores on the checklist →

---

Why purity and identity are structurally blind to contamination

Reversed-phase HPLC separates the peptide from its synthesis-related impurities and reports the main peak as a percentage of total peak area, usually with UV detection near 214-220 nm. Mass spectrometry compares the observed mass against the theoretical mass for the sequence. Both are covered in detail in our guide to reading a peptide COA.

Neither method is looking for a microorganism or a lipopolysaccharide:

Question	Instrument / method	Standard	Reported as
Which molecule is it?	Mass spectrometry	Compendial identity testing	Observed vs theoretical mass
How much of the peptide material is the target?	RP-HPLC with UV	Method-specific	% main peak area
Are viable microorganisms present?	Culture in two media, 14 days	USP <71> Sterility Tests	Growth / no growth
How much microbial load is present?	Plate count	USP <61> (TAMC / TYMC)	CFU per unit
How much bacterial endotoxin is present?	LAL cascade	USP <85> Bacterial Endotoxins Test	EU per mL, per vial, or per mg
Same question, animal-free reagent	Recombinant Factor C or recombinant cascade	USP <86> (official May 2025)	EU per mL, per vial, or per mg

A bacterial cell would not produce a UV peak at a retention time anyone is watching, and lipopolysaccharide is a heterogeneous amphiphilic macromolecule that does not appear as a clean species in a peptide MS window. The blindness is structural, not a matter of the lab being careless. If you want a contamination answer you have to pay for a contamination test.

---

Bacterial endotoxin testing: what the assay is and what EU/mg means

Endotoxin is lipopolysaccharide from the outer membrane of Gram-negative bacteria. It survives autoclaving, it survives sterile filtration in the sense that it passes through a 0.22 um filter, and it is not removed by the fact that a preparation is sterile. A sample can pass a sterility test and still carry a high endotoxin load, because sterility asks “is anything alive in here” and endotoxin testing asks “is there bacterial debris in here.”

The four compendial methods

USP <85> describes two families of technique: gel-clot, which is a visual endpoint based on clot formation, and photometric methods, split into turbidimetric (measures turbidity development) and chromogenic (measures colour released when the activated enzyme cleaves a synthetic peptide-chromogen substrate). All three run on Limulus amebocyte lysate, an extract from horseshoe crab blood.

USP <86>, Bacterial Endotoxins Test Using Recombinant Reagents, covers the animal-free alternatives: recombinant Factor C (rFC), which uses only the first enzyme of the cascade with a fluorogenic readout, and recombinant cascade reagents (rCR), which reconstitute more of the cascade. USP published the final text on 1 November 2024 for early adoption and the chapter became official in May 2025. Independent validation across 19 pharmaceutical products at Eli Lilly reported the rFC method equivalent or superior to the compendial LAL test for accuracy, linearity, precision and robustness (Bolden & Smith, PDA J Pharm Sci Technol 2017, PMID 28733334).

Practically: if a report says rFC instead of LAL, that is not a downgrade. It is the newer compendial route, and in a head-to-head against divergent lipopolysaccharide structural species, the rFC assay was the only method whose readings correlated significantly with IL-6 release from a monocytic cell line - the authors concluded it is a viable replacement for conventional LAL (Abate et al., J Med Microbiol 2017, PMID 28693666).

Reading the unit without getting fooled

The Endotoxin Unit is a potency unit calibrated to a reference standard, not a mass. Against the current USP/FDA Reference Standard Endotoxin (the EC-6 lot), roughly 10 EU corresponds to 1 ng of that standard endotoxin; older literature using EC-2 used 5 EU/ng, which is why decades-old conversions disagree. The reference standards themselves are set by international collaborative study - the WHO 3rd International Standard, the Ph. Eur. BRP batch 5 and the USP Reference Standard for Endotoxin were established together across 35 laboratories, with an assigned value of 10,000 IU per vial (Findlay et al., Pharmeur Bio Sci Notes 2015, PMID 26830160).

Three denominators show up on real reports, and they are not interchangeable:

Reported as	What it means	How to normalize
EU/mL	Concentration in a solution as tested	Depends entirely on the dilution the lab used
EU/vial	Total endotoxin in the container	Divide by net peptide content in mg to get EU/mg
EU/mg	Mass-normalized, the comparable figure	Already comparable across vendors and vial sizes

Worked example. A lab reports 5 EU/vial on a vial whose COA states 10 mg net peptide content. That is 5 / 10 = 0.5 EU/mg. The same 5 EU in a 2 mg vial is 2.5 EU/mg, five times worse, from an identical-looking headline number. This is exactly why you should read the endotoxin line together with the net-content line, and it is the same arithmetic discipline as our cost-per-mg calculator.

The second trap is EU/ug versus EU/mg, which differ by 1,000x. A commercial low-endotoxin peptide service such as GenScript advertises endotoxin control to <0.01 EU/ug, which is <10 EU/mg. A supplier advertising <0.1 EU/mg is claiming a spec one hundred times tighter. Both are real specifications; a reader who skims the number and ignores the denominator will rank them backwards. Commercial specs vary widely by supplier and by grade, so compare only after converting to a single denominator.

For context on where these numbers come from at all: pharmacopeial endotoxin limits for parenteral drug products are derived by calculation in USP <85>, using a constant K of 5 EU per kg of body weight for routes other than intrathecal (0.2 EU/kg intrathecal), divided by the maximum dose. That framework does not apply here. Research-use-only material is not administered to humans or animals, so there is no dose to divide by and no human limit to compute. The useful reference points for research material are instead mass-normalized supplier specs and monograph values for the things you handle alongside it - USP Water for Injection and Sterile Water for Injection, for instance, carry a monograph limit of less than 0.25 EU/mL.

Why trace endotoxin is a research problem, not a paperwork problem

Endotoxin is a potent TLR4 agonist and is biologically active at picogram-per-millilitre concentrations. That is far below anything a purity assay would notice.

The cleanest published demonstration: residual endotoxin contamination in commercially available recombinant proteins was sufficient to activate human CD1c+ dendritic cells, with lipopolysaccharide tested across 0.002 to 2 ng/mL producing activation at levels “equivalent to the levels of endotoxin contamination” the authors detected in commercial preparations (Schwarz et al., PLoS One 2014, PMID 25478795). The lower bound there, 0.002 ng/mL, is about 0.02 EU/mL.

The same failure mode has been documented repeatedly outside protein work. In one cell-therapy QC investigation, endotoxin in the culture supernatant exceeded the criterion value and was eventually traced to a cholera toxin reagent - three separate lots of which carried endotoxin above the allowable threshold, even though individual reagents had tested acceptable in isolation (Uehara et al., Regen Ther 2024, PMID 38596824). In nanomaterial research, endotoxin contamination is recognized as a systematic cause of misinterpreted immunosafety results, to the point that reviews recommend testing before any immunological assay is run (Smulders et al., Part Fibre Toxicol 2012, PMID 23140310).

The consequence for a research model is specific: an apparent anti-inflammatory, pro-inflammatory, proliferative or cytotoxic “effect” of the test article may be TLR4 signalling from the contaminant. You do not get a warning. You get a result.

Where the assay itself can be wrong

Two interference modes matter enough that compendial methods require suitability testing:

1. False positives from beta-glucans. Glucans activate a pathway in amebocyte lysate that is independent of the endotoxin response, producing a false endotoxin reading. Glucan-blocking buffers exist; rFC, which uses only Factor C, is not driven by the glucan pathway.
2. Low endotoxin recovery (LER, “masking”). In formulations containing chelating agents plus surfactants, spiked endotoxin becomes undetectable over time. LER is conventionally defined as failure to recover more than 50% of spiked activity across a hold period. Critically, masking susceptibility depends on the endotoxin source - bacterial strain and growth conditions change the result, so you cannot predict whether a sample will mask without spiking with a variant known to be vulnerable (Reich et al., Int J Mol Sci 2019;20(4):838, PMID 30781342). FDA’s 2012 Pyrogen and Endotoxins Testing: Questions and Answers guidance is the regulatory anchor for hold-time expectations.

A report that states the method, the sensitivity (lambda), and that positive product control / interference testing was performed is doing the job. A bare number with no method named is not.

---

Sterility testing: USP <71>, and the count that is not a sterility test

What USP <71> actually is

USP <71> is a culture test, not an instrument reading. The article is either filtered through a membrane of nominal pore size 0.45 um or smaller, or inoculated directly, into two media:

Medium	Incubation temperature	Targets
Fluid Thioglycollate Medium (FTM)	30-35 C	Bacteria, including anaerobes
Soybean-Casein Digest Medium (SCDM / TSB)	20-25 C	Aerobic bacteria and fungi

Both are incubated for a minimum of 14 days, and each medium lot must pass growth-promotion checks before the test is valid. The result is binary: growth or no growth.

The number of containers pulled is set by batch size. For parenteral preparations, USP <71> specifies:

Batch size (containers)	Minimum containers tested per medium
Not more than 100	10%, or 4, whichever is greater
101 to 500	10
More than 500	2%, or 20, whichever is less

The honest limitation, stated by USP itself

That sampling scheme is the whole reason a sterility pass is a weaker claim than people assume. USP <1211> states directly that the sterility test may not detect microbial contamination present in only a small percentage of finished articles in a lot, because the specified number of units imposes a significant statistical limitation on the utility of the result. Widely cited worked examples put the detection probability for a 1% contamination rate in a large batch in the low tens of percent.

Read that the way you should read any COA: a sterility pass proves that the sampled units grew nothing in 14 days. It does not certify the lot, and it certainly does not certify your vial. It is the same caveat that applies to purity testing, which is why lot matching is the load-bearing step in COA verification generally.

TAMC/TYMC is a bioburden count, not sterility

This distinction is quietly load-bearing in the peptide sector. Janoshik Analytical, one of the two labs most often named on peptide COAs, lists sterility testing on its price list as TAMC + TYMC cultivation, requiring unopened vials to avoid contamination in transit, and lists endotoxin analysis separately as an LAL assay, noting the standard test is accurate for values up to 10 EU/vial and that it is not offered on oils, raw API powders, tablets or capsules.

TAMC (total aerobic microbial count) and TYMC (total yeast and mold count) are the enumeration tests of USP <61>, written for non-sterile products, reported quantitatively in CFU, using soybean-casein digest agar at 30-35 C for 3-5 days and Sabouraud dextrose agar at 20-25 C for 5-7 days. USP <71> is qualitative, runs 14 days, and is written for articles labelled sterile.

So when a vendor says “sterility tested,” the checkable follow-up is: which test? A TAMC/TYMC count of zero is a genuinely useful bioburden signal and more than most vendors provide. It is not a USP <71> sterility certification, and a vendor conflating the two is either sloppy or hoping you will not ask. Note also the reporting unit above: Janoshik reports endotoxin per vial, so you must divide by net peptide content yourself to get the comparable EU/mg.

---

The diluent and the handling are part of the same chain

A contamination result on lyophilized powder is a snapshot of the powder, and the chain does not end there. Bacteriostatic Water for Injection, USP is labelled sterile and non-pyrogenic and contains 0.9% (9 mg/mL) benzyl alcohol as a bacteriostatic preservative in a multiple-dose container; Sterile Water for Injection carries no preservative and its monograph endotoxin limit is under 0.25 EU/mL.

Three practical points for lab handling of research material:

1. A preserved diluent inhibits growth; it does not sterilize anything and it does not touch endotoxin. Benzyl alcohol is bacteriostatic, not sporicidal, and lipopolysaccharide is unaffected.
2. Every septum entry is an opportunity. Vial stoppers and working surfaces are the usual real-world entry point, not the powder.
3. Endotoxin can arrive from the water and the glassware, which is exactly why WFI has its own monograph limit. If you are working out volumes, our reconstitution calculator and syringe units calculator are for the arithmetic only; the microbiology is a separate discipline with its own controls, and our bacteriostatic water guide covers the diluent side.

---

What this means for vetting a vendor

Here is the honest state of the market: the overwhelming majority of research-peptide vendors publish purity and identity only. Peptide endotoxin testing and sterility testing cost extra per batch, and there is currently no commercial pressure forcing either one, because buyers do not ask. So the realistic grading is not “does this vendor have a full USP-grade QC package” - almost none do - but “how far up this ladder do they go, and are they honest about where they stop.”

Tier	What the vendor publishes	How to verify
0	“Lab tested” or “99% pure” with no document	Nothing to verify. Disqualifying.
1	A COA image, no lab named, no accession code	Not verifiable. Treat as marketing.
2	Named third-party lab, HPLC + MS, verifiable accession, lot matches vial	Re-open the record at the lab’s own site
3	Tier 2 plus a microbial result (TAMC/TYMC bioburden or USP <71>)	Confirm which test was actually run
4	Tier 3 plus an endotoxin result with method and units stated	Convert to EU/mg using net peptide content

Questions that are fair to ask a vendor, and whose answers are checkable:

1. Which contamination tests, if any, were run on this lot? “Third-party tested” is not an answer to this question.
2. If endotoxin was tested: which method - gel-clot, turbidimetric, chromogenic LAL, or rFC/rCR? And what was the assay sensitivity?
3. In what unit was it reported, and what is the net peptide content? You need both to compute EU/mg.
4. If a microbial result exists: is it USP <71> sterility or a USP <61>-style TAMC/TYMC count? These are different claims.
5. Does the accession number on the contamination report resolve on the lab’s own site, and does the lot on that report match the number printed on the vial?
6. If no contamination testing was done, will the vendor say so in writing? A vendor that plainly states “our COAs cover purity and identity only” is more trustworthy than one whose marketing lets a 99% figure imply cleanliness.

Question 6 is the real discriminator. Absence of endotoxin data is normal in this market. Implying endotoxin data you do not have is a red flag, and it belongs on the same list as the ones in our vendor red flags and US vendor vetting guides. You can score any vendor against these tiers with our vendor transparency scorecard.

---

How Pepora scores

Applying the ladder above honestly, including where it does not reach.

What is verifiable. Pepora (peporalabs.com) publishes third-party reports from Freedom Diagnostics, a US lab running HPLC and mass spectrometry, each verifiable by search code at the lab’s own site, FreedomDiagnosticsTesting.com:

Product	Purity	Accession
GHK-Cu	99.98%	Pepo2603130126
Tesamorelin	99.348%	Pepo2603130125
TB-500 (Thymosin Beta-4)	99.699%	Pepo2603130123
GLP-3 RT	99.67%	Pepo2603130122

That is Tier 2: named independent lab, both purity and identity, results you can re-open yourself rather than take on trust. Orders ship from the US.

The caveats, stated plainly.

• Those four accessions cover four SKUs, not the catalogue. BPC-157, Epitalon, Thymosin Alpha-1, ARA-290 and the KLOW / Glow / Wolverine blends do not have a Freedom Diagnostics accession listed above, and this page will not pretend otherwise. For those, treat the vendor as untested-until-shown and ask for the lot-specific report before buying.
• These are purity and identity reports. They are HPLC and mass spectrometry. They are not USP <71> sterility results and they are not bacterial endotoxin results. On the ladder above, Pepora does not currently reach Tier 3 or Tier 4, and neither do most of its competitors.
• A COA certifies a sampled lot, not your vial. Match the accession’s lot to the number printed on what you receive.

The reason Pepora is the disclosed pick below is Tier 2 done verifiably on its named SKUs, not a contamination package it does not publish. If contamination data is a hard requirement for your work, the correct move is to commission an endotoxin and TAMC/TYMC panel on your own lot from an independent lab - that option is available to buyers, and no vendor’s marketing substitutes for it.

---

The disclosed pick

---

FAQ

Does a 99% purity COA mean a peptide is sterile and endotoxin-free? No. HPLC measures how much of the peptide material is the target compound and mass spectrometry confirms which molecule it is. Neither instrument detects viable microorganisms or bacterial endotoxin. Sterility is a separate culture-based test (USP <71>) and endotoxin is a separate biochemical assay (USP <85> or <86>). A purity-only COA is silent on both.

What does EU/mg mean on a peptide report? EU stands for Endotoxin Unit, a potency unit tied to a reference standard rather than a raw mass. Against the current USP/FDA reference standard endotoxin, roughly 10 EU corresponds to 1 ng of that standard endotoxin. EU/mg normalizes the result to the mass of peptide, so a 10 mg vial reported at 5 EU/vial is 0.5 EU/mg. Watch the units: EU/ug and EU/mg differ by a factor of 1,000.

What is the difference between LAL and recombinant Factor C testing? LAL uses a clotting cascade extracted from horseshoe crab amebocyte lysate and is the method described in USP <85>. Recombinant Factor C (rFC) and recombinant cascade reagents use engineered proteins instead of animal lysate and are described in USP <86>, which USP published in November 2024 and made official in May 2025. Published comparability work found rFC equivalent or superior to the compendial method.

Is a TAMC/TYMC result the same as a sterility test? No, and this is a common misread. TAMC (total aerobic microbial count) and TYMC (total yeast and mold count) are quantitative enumeration tests from USP <61>, designed for non-sterile products and reported in colony-forming units. USP <71> is a pass/fail sterility test on a sterile-labelled article, incubated 14 days in two media. A low TAMC/TYMC count is a bioburden number, not a sterility claim.

Why would trace endotoxin ruin a research model? Endotoxin is a potent TLR4 agonist that is biologically active at picogram-per-millilitre levels. One peer-reviewed study found that residual endotoxin at 0.002 to 2 ng/mL, within the tolerance of some commercial protein preparations, was enough to activate human CD1c+ dendritic cells. Any readout involving immune cells, cytokines or viability can therefore reflect the contaminant rather than the compound.

Can an endotoxin assay give a wrong answer? Yes, in both directions. Beta-glucans can activate the LAL cascade and produce a false positive, and formulation components such as chelators plus surfactants can mask spiked endotoxin, a documented effect called low endotoxin recovery. Compendial testing therefore requires interference and method-suitability checks, and regulators expect hold-time studies for products prone to masking.

---

References

1. Bolden J, Smith K. Application of Recombinant Factor C Reagent for the Detection of Bacterial Endotoxins in Pharmaceutical Products. PDA Journal of Pharmaceutical Science and Technology. 2017;71(5):405-412. PMID 28733334 · doi:10.5731/pdajpst.2017.007849
2. Schwarz H, Schmittner M, Duschl A, Horejs-Hoeck J. Residual Endotoxin Contaminations in Recombinant Proteins Are Sufficient to Activate Human CD1c+ Dendritic Cells. PLoS One. 2014;9(12):e113840. PMID 25478795 · doi:10.1371/journal.pone.0113840
3. Reich J, Weyer FA, Tamura H, Nagaoka I, Motschmann H. Low Endotoxin Recovery - Masking of Naturally Occurring Endotoxin. International Journal of Molecular Sciences. 2019;20(4):838. PMID 30781342 · doi:10.3390/ijms20040838
4. Abate W, Sattar AA, Liu J, Conway ME, Jackson SK. Evaluation of recombinant factor C assay for the detection of divergent lipopolysaccharide structural species and comparison with Limulus amebocyte lysate-based assays and a human monocyte activity assay. Journal of Medical Microbiology. 2017;66(7):888-897. PMID 28693666 · doi:10.1099/jmm.0.000510
5. Smulders S, Kaiser JP, Zuin S, et al. Contamination of nanoparticles by endotoxin: evaluation of different test methods. Particle and Fibre Toxicology. 2012;9:41. PMID 23140310 · doi:10.1186/1743-8977-9-41
6. Uehara K, Oshiro E, Ochiai A, Takagi R, Yamato M, Kato A. Lessons learned from contamination with endotoxin originated from the supplement in the cell culture medium. Regenerative Therapy. 2024;27:230-233. PMID 38596824 · doi:10.1016/j.reth.2024.03.022
7. Findlay L, Desai T, Heath A, Poole S. Collaborative study for the establishment of the WHO 3rd International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354. Pharmeuropa Bio & Scientific Notes. 2015;2015:73-98. PMID 26830160
8. United States Pharmacopeia. General Chapter <85> Bacterial Endotoxins Test. usp.org - Bacterial Endotoxins harmonized text
9. United States Pharmacopeia. General Chapter <86> Bacterial Endotoxins Test Using Recombinant Reagents - published 1 November 2024 for early adoption, official May 2025. usp.org announcement · USP-NF general announcement
10. United States Pharmacopeia. General Chapter <71> Sterility Tests (harmonized text, media, incubation and sampling tables). usp.org PDF
11. United States Pharmacopeia. General Chapter <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests (TAMC / TYMC). usp.org PDF
12. U.S. Food and Drug Administration. Guidance for Industry: Pyrogen and Endotoxins Testing: Questions and Answers (June 2012). fda.gov
13. U.S. Food and Drug Administration. Inspection Technical Guide: Bacterial Endotoxins/Pyrogens. fda.gov
14. USP Monographs: Water for Injection and Sterile Water for Injection (endotoxin limit less than 0.25 USP EU/mL). uspbpep.com monograph text
15. GenScript. Peptide Endotoxin Control & Analysis Service (endotoxin control to <0.01 EU/ug). genscript.com
16. Janoshik Analytical. Endotoxin analysis (LAL, accurate up to 10 EU/vial) and Sterility testing (TAMC+TYMC) service listings. janoshik.com/services
17. Pfizer. Bacteriostatic Water for Injection, USP prescribing information (0.9% benzyl alcohol, multiple-dose vial). labeling.pfizer.com

---

coaindex is a Pepora affiliate (peporalabs.com) and earns a commission on purchases made with the code above. This is affiliate education, not journalism, and it ranks vendors on checkable, independently verifiable third-party-COA criteria. Research use only. Not for human or veterinary use, and nothing here is medical advice.